A Phaedon Institute Initiative

The Podcast . .. ...

EPISODE #003

Dr. Elena Itskovich hosts Dr. Marco Quarta and Dr. Simone Fantaccini to discuss the development of senolytic therapeutics, collaboration between academia, pharma, biotech industry and more. They discuss how these collaborations can bring the field forward and bring therapeutics to market.

Join us in this thought-provoking episode as we learn more about the goals and objectives of the Seno-Therapeutics Summit by the Phaedon Institute, a highly curated and professional forum that brings together stakeholders from academia, biotechnology, pharmaceuticals, investors, and regulatory bodies to promote advances in the field, support collaboration and coordination, and accelerate research for the benefit of the aging population affected by chronic degenerative diseases.

EPISODE #002

Dr. Elena Itskovich hosts Dr. Marco Quarta and Dr. Paul Robbins to discuss the groundbreaking field of Senolytics research and therapeutic development. They discuss how this cutting-edge research is reshaping the landscape of medicine and offering new hope for age-related diseases.

Join us in this thought-provoking episode as we learn more about the goals and objectives of the Seno-Therapeutics Summit by the Phaedon Institute, a highly curated and professional forum that brings together stakeholders from academia, biotechnology, pharmaceuticals, investors, and regulatory bodies to promote advances in the field, support collaboration and coordination, and accelerate research for the benefit of the aging population affected by chronic degenerative diseases.

EPISODE #001

Dr. Marco Quarta, Prof. Marco Demaria and Dr. Elena Itskovich introduce the Phaedon Institute, the 2023 Senotherapeutics Summit and the idea behind the podcast.

About the Podcast

The Phaedon Podcast is a dedicated space aimed to facilitate the exchange of ideas and opinions before, during and after the Summit.

The Podcast is one of the ways in which we want to achieve the goal of forming connections between the different stakeholders in aging research and therapeutics as well as keep an open route of information sharing between aging and longevity experts and the public.

Listen on:

Spotify or Apple Podcasts

This website uses cookies to ensure you get the best experience on our website.